Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption.

The in vitro corneal penetration and in vivo corneal absorption of acyclovir from an acyclovir-containing liposome system were investigated. Results of in vitro corneal penetration demonstrated that positively charged liposomes resulted in a penetration rate lower than those of negatively charged liposomes and free acyclovir in solution. An in vivo study indicated that the extent of acyclovir absorption from positively charged liposomes was higher that those from negatively charged liposomes and free acyclovir. The acyclovir concentration in the cornea after administration of positively charged liposomes showed that an acyclovir deposition in the cornea was greater than those of negatively charged liposomes and free acyclovir. From morphological observation of the cornea surface treated with liposomes, it was suggested that positively charged liposomes formed a completely coated layer on the cornea surface. These liposomes would bind intimately on the cornea surface, leading to an increase of residence time. Therefore, positively charged liposomes resulted in an increase of acyclovir (ACV) absorption.

[1]  A. Mitra,et al.  Effect of acylation on the ocular disposition of acyclovir. II: Corneal permeability and anti-HSV 1 activity of 2'-esters in rabbit epithelial keratitis. , 1993, Journal of ocular pharmacology.

[2]  Kuldeep Singh,et al.  Liposomal ophthalmic drug delivery system. II. Dihydrostreptomycin sulfate , 1984 .

[3]  D. Krohn,et al.  Liposomes in topical drug delivery. , 1982, Investigative ophthalmology & visual science.

[4]  V. H. Lee,et al.  Topical ocular drug delivery: recent developments and future challenges. , 1986, Journal of ocular pharmacology.

[5]  S. Law,et al.  Properties of acyclovir-containing liposomes for potential ocular delivery , 1998 .

[6]  R. Schoenwald,et al.  Corneal Penetration Behavior of β-Blocking Agents I: Physicochemical Factors , 1983 .

[7]  H. Edelhauser,et al.  The corneal penetration of trifluorothymidine, adenine arabinoside, and idoxuridine: a comparative study. , 1977, Investigative ophthalmology & visual science.

[8]  I. Kellaway,et al.  Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system , 1992 .

[9]  M. Ercan,et al.  In-vivo studies on dexamethasone sodium phosphate liposomes. , 1996, Journal of microencapsulation.

[10]  R. Radhakrishnan,et al.  Adhesion of Positively Charged Liposomes to Mucosal Tissues , 1989 .

[11]  K. De Clercq,et al.  Topical treatment of experimental herpes simplex keratouveitis with 2'-O-glycylacyclovir. A water-soluble ester of acyclovir. , 1984, Archives of ophthalmology.

[12]  Kuldeep Singh,et al.  Liposomal ophthalmic drug delivery system I. Triamcinolone acetonide , 1983 .

[13]  K. Morisaki,et al.  Efficacy of a liposome preparation of anti-inflammatory steroid as an ocular drug-delivery system. , 1988, Journal of pharmacobio-dynamics.